Moneycontrol Be a Pro
Get App
Last Updated : Jan 09, 2019 10:09 AM IST | Source: Moneycontrol.com

Transgene Biotek locked at upper circuit as US grants patent approval

There were pending buy orders of 471,870 shares, with no sellers available.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Shares of Transgene Biotek locked at 5 percent upper circuit after United States of America granted patent on technology for oral delivery of insulin and insulin analogues.

There were pending buy orders of 471,870 shares, with no sellers available.

This intimation of patent being granted by USA will strengthen the company's management to justifiably increase its monetary value of its technology for oral delivery if Insulin and its analogues, company said in release.

Close

At 09:43 hrs Transgene Biotek was quoting at Rs 3.88, up Rs 0.18, or 4.86 percent on the BSE.

For more market news, click here

Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on Jan 9, 2019 10:09 am
Loading...
Sections
Follow us on
Available On